Aldesleukin Withdrawn Phase 2 Trials for Crohn's Disease (CD) Treatment

IndicationsStatusPurposePhase
WithdrawnTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02676622Autologous Stem Cell Transplant for Refractory Crohn's Disease